Psychedelics: Past, Present, and Future

Description

Presenter: Joseph McCowan, Psy.D

Dr. Joseph McCowan is a licensed clinical psychologist based in Los Angeles with extensive experience in psychedelic-assisted therapy, clinical research, and education. He served as a Co-Therapist and Supervisor in the MAPS-sponsored Phase 3 clinical trials of MDMA-Assisted Therapy for PTSD and contributed to the MAPS Therapy Training and Education program as a Lead Educator and Consultant. As a member of the MAPS Diversity Working Group, Dr. McCowan advanced initiatives to increase inclusion and representation in clinical studies.

He is currently a therapist in Compass Pathways’ Phase 3 trials of Psilocybin-Assisted Therapy for Treatment-Resistant Depression and serves as a Lead Trainer with Fluence, where he educates mental health professionals in Psychedelic-Assisted Therapy. Previously, Dr. McCowan provided Ketamine-Assisted Psychotherapy and psychedelic integration services at the California Center for Psychedelic Therapy.

Dr. McCowan holds a doctorate in clinical psychology from the Chicago School of Professional Psychology and a bachelor’s degree in psychology from the University of California, Santa Barbara. He serves on the Board of Directors for Chacruna and Lykos Therapeutics and is deeply committed to increasing access to psychedelic therapies for historically underserved communities.

 Overview:         

This webinar provides a foundational introduction to psychedelics and Psychedelic-Assisted Therapy (PAT), offering participants a comprehensive and critical overview of the field. The presentation explores the diverse range of psychedelic compounds and traces their use across time and cultures, emphasizing indigenous traditions and ceremonial practices. It examines the emergence of psychedelic science in the West, highlighting pivotal moments in 20th-century research as well as recent developments in clinical studies.

The course will also explore the historical and ongoing marginalization of communities within psychedelic research, with particular attention to cultural appropriation and ethical concerns. The presentation aims to offer a nuanced understanding of the promise and complexity of psychedelic-assisted care while honoring its cross-cultural roots and advocating for equity and inclusion in the field’s future.

Learning Objectives: 

1. Identify major psychedelic compounds and their therapeutic applications.

2. Describe the historical and cross-cultural use of psychedelics.

3. Discuss ethical considerations, including cultural appropriation and the impact on marginalized communities.

CE Credits Available: 1.0 

PLEASE NOTE: You must sign in to receive the Member discount. After purchasing, you must follow the link in your receipt provided to REGISTER for the webinar via Zoom. It is a 2-step process. If a link does not appear, contact us. 

Cancellation Policy: No refunds will be provided except when SCP cancels the webinar. 

The Society of Clinical Psychology, Division 12 does not have commercial support for the content of this webinar including endorsement of products, conflict of interest including but not limited to research grants, royalties for books or training, commercial support from companies or pharmaceutical sponsorship. 

Dr. McCowan Conflicts of Interest

Board of Directors – Lykos Therapeutics

Study Therapist – Compass Pathways

Study Therapist – Multidisciplinary Association for Psychedelic Studies

Attendees must attend the entirety of the program and complete the Evaluation sent after the program.  Evaluations will be sent via email shortly after the Live webinar.  CE Certificates will be processed and emailed within 5 – 10 business days from Live Webinar.

If you require any special needs assistance, please contact the SCP Central Office at division12apa@gmail.com.